Cass Freeland Builds Relationships with Political Power Players
NDAM Profile: Breakthrough T1D advocate Cass Freeland’s expertise in connecting with policy makers demonstrates The Power of Us.
FDA Approves an Artificial Pancreas System for Children Aged 2-6 Years
The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2…
Executive Orders on Drug Pricing
On July 24, the White House released three Executive Orders related to drug pricing.
Nation’s Largest Insurer Expands Insulin Pump Coverage
In a victory for Breakthrough T1D’s Coverage2Control Campaign, people with T1D now have more choice in how they manage their…
JDRF’s One Night: The Power of Us Is Unstoppable
One Night. One Community. One Purpose: to show the world the undeniable power of people living with T1D.
Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology…
Breakthrough T1D Top Advances Over the Past Year
At Breakthrough T1D, we are committed to funding the development of new therapies to keep people with type 1 diabetes…
